Point-of-Care (POC) Coagulation Testing Market Developments Shaping Growth Across The Forecast Period
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Market Size Estimates For The Point-of-Care (POC) Coagulation Testing Market In 2026 And 2030?
The point-of-care (poc) coagulation testing market size has experienced steady expansion in recent years. It is forecast to grow from $1.25 billion in 2025 to $1.3 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.2%. This growth during the historical period is largely attributable to the increasing prevalence of cardiovascular diseases that require anticoagulation therapy, a heightened demand for quick coagulation results in operating rooms and ICUs, the early clinical adoption of optical and mechanical poc testing platforms, the broadened implementation of coagulation monitoring in both hospital and clinic environments, and rising awareness of point-of-care diagnostics for enhancing treatment efficacy.
The point-of-care (poc) coagulation testing market is anticipated to experience consistent expansion over the coming years. Its valuation is projected to reach $1.52 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.1%. This expansion during the projection period stems from a greater move towards decentralized and in-home coagulation monitoring, increased application of electrochemical detection methods, higher volumes of procedures in emergency and trauma care, broader availability through retail and direct tender distribution, and a heightened emphasis on shortening turnaround times and enhancing treatment outcomes. Key trends for this upcoming period encompass the surging uptake of swift bedside coagulation tests in critical and urgent care, wider deployment of poc coagulation instruments for monitoring anticoagulation therapy, a developing partiality for mobile and compact coagulation analyzers, the broadening application of coagulation testing in home care and outpatient facilities, and a rising need for immediate clinical decision support via near-patient testing.
Access Your Free Sample Report For In-Depth Market Analysis:
What Primary Drivers Are Shaping The Point-of-Care (POC) Coagulation Testing Market?
The growing occurrence of cardiovascular diseases is projected to drive the expansion of the point-of-care (POC) coagulation testing market in the future. Cardiovascular diseases (CVDs) encompass various heart and blood vessel conditions, such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease. Point-of-care (POC) coagulation testing proves beneficial in managing cardiovascular diseases (CVDs) by offering real-time data on coagulation, which facilitates prompt decisions regarding interventions and minimizes the risk of post-cardiac surgery bleeding complications. As an illustration, in October 2024, the Centers for Disease Control and Prevention, a US-based public health institute, reported that in 2023, approximately 1 out of every 6 cardiovascular disease deaths occurred in adults younger than 65 years old, with 919,032 people succumbing to cardiovascular disease, accounting for 1 in every 3 deaths. Consequently, the increased prevalence of cardiovascular diseases is fueling the expansion of the point-of-care (POC) coagulation testing market.
Which Segment Categories Are Included In The Point-of-Care (POC) Coagulation Testing Market Segment Analysis?
The point-of-care (poc) coagulation testing market covered in this report is segmented –
1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
2) By Distribution Channel: Direct Tenders, Retail
3) By End-User: Hospitals, Clinics, Home care
Subsegments:
1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection
2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection
3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection
What Trends Are Affecting The Growth Of The Point-of-Care (POC) Coagulation Testing Market?
Major companies within the point-of-care (POC) coagulation testing market are concentrating on developing innovative connected POC coagulation solutions. They achieve this through strategic collaborations to gain a competitive advantage in the market. A strategic collaboration is a formal arrangement between multiple parties that agree to work together toward specific, mutually beneficial, predetermined goals. As an illustration, in January 2023, Jana care, a US-based company specializing in biomarker assays for its proprietary digital health platform, collaborated with Roche Diagnostics. Roche Diagnostics, a Switzerland-based firm, develops diagnostic tests, instruments, and digital solutions designed to transform healthcare. This partnership intends to develop and distribute a point-of-care blood testing platform aimed at screening for chronic kidney disease and heart failure. This groundbreaking platform will enable patients to perform blood tests at home, with clinicians subsequently reviewing the results remotely.
Who Are The Active Companies Shaping The Point-of-Care (POC) Coagulation Testing Market?
Major companies operating in the point-of-care (poc) coagulation testing market are Siemens Healthcare GmbH, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc
Get The Full Point-of-Care (POC) Coagulation Testing Market Report:
Which Region Is The Leading Market For The Point-of-Care (POC) Coagulation Testing Market?
North America was the largest region in the point-of-care (POC) coagulation testing market in 2025. The regions covered in the point-of-care (poc) coagulation testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Point-of-Care (POC) Coagulation Testing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Point-of-Care (POC) Coagulation Testing Market 2026, By The Business Research Company
Point Of Care Poc Coagulation Testing Market Report 2026
Point Of Care Diagnostics Devices And Equipment Market Report 2026
Point Of Care Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
